Phreesia, Inc. (NYSE:PHR) SVP Sells $294,547.05 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,853 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $24.85, for a total value of $294,547.05. Following the transaction, the senior vice president now owns 188,354 shares of the company’s stock, valued at $4,680,596.90. This represents a 5.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

David Linetsky also recently made the following trade(s):

• On Friday, October 18th, David Linetsky sold 1,100 shares of Phreesia stock. The shares were sold at an average price of $20.49, for a total transaction of $22,539.00.
• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total transaction of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total transaction of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The stock was sold at an average price of $24.77, for a total value of $891.72.

Phreesia Stock Performance

Shares of NYSE:PHR opened at $24.94 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The firm has a market cap of $1.45 billion, a PE ratio of -16.97 and a beta of 0.98. The firm’s 50 day simple moving average is $20.45 and its 200-day simple moving average is $21.81. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same period in the previous year, the company posted ($0.58) EPS. Phreesia’s revenue was up 16.6% on a year-over-year basis. As a group, equities analysts predict that Phreesia, Inc. will post -1.22 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on PHR. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday. Royal Bank of Canada reiterated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. JPMorgan Chase & Co. raised their target price on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. Finally, DA Davidson reaffirmed a “buy” rating and set a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and an average price target of $29.33.

Institutional Trading of Phreesia

A number of hedge funds have recently added to or reduced their stakes in the business. Champlain Investment Partners LLC raised its holdings in shares of Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after purchasing an additional 97,847 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. State Street Corp increased its holdings in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares during the period. Geode Capital Management LLC increased its holdings in Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after buying an additional 55,934 shares during the period. Finally, TimesSquare Capital Management LLC raised its stake in Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after buying an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.